Tetrahydrocannabivarin
CAS: 31262-37-0
Ref. TM-TN5131
1mg | 1,087.00 € | ||
5mg | 2,181.00 € | ||
10mg | 2,942.00 € | ||
25mg | 4,381.00 € | ||
50mg | 5,932.00 € | ||
100mg | 7,961.00 € |
Product Information
- THCV, delta9-Tetrahydrocannabivarin, CRM, Tetrahydrocannavarin
- (-)-Δ<sup>9</sup>-trans-Tetrahydrocannabivarin
- (6AR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol
- (6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo[b,d]pyran-1-ol
- 6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR-trans)-
- 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (-)-
- 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR,10aR)-
- Cannabidivarol, Δ<sup>1</sup>-tetrahydro-
- Cannabivarol, Δ<sup>9</sup>-tetrahydro-
- O 4394
- See more synonyms
- Tetrahydrocannabinol-C3
- Thc-C3
- Thc-V
- n-Propyl-Δ<sup>9</sup>-tetrahydrocannabinol
- Δ<sup>1</sup>-Tetrahydrocannabidivarol
- Δ<sup>9</sup>-Tetrahydrocannabivarin
- Δ<sup>9</sup>-Tetrahydrocannabivarol
Tetrahydrocannabivarin (CRM) is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in obesity, perhaps with a lowered risk of depressive side effects. Tetrahydrocannabivarin exhibits anticonvulsant effects in a piriform cortical brain slice model of epileptiform activity.
Chemical properties
Technical inquiry about: TM-TN5131 Tetrahydrocannabivarin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.